Summary
- Current Price
- As of today, DFTX price is $17.66, up +0.63% on
- Current Price All-Time High
- DFTX price is currently -79.60% below its historical high of $86.55 set on
- Market Cap
- DFTX current market cap is $2B, up +244.63% over the past 365 days
- PE Ratio
- DFTX PE ratio is unknown
- Revenue
- DFTX current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- The next earnings release for DFTX is on
Profile
| Metric | Value |
|---|---|
| Full Name | Definium Therapeutics, Inc. |
| Ticker | NASDAQ: DFTX |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | definiumtx.com |
| Employees | 74 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $17.66 | |
| Price, 1D Change | +0.63% | |
| $2B | ||
| - | ||
| - | ||
| 1.52 | ||
| $0 | ||
| Revenue, 1Y Change | 0.00% | |
| $0.00 | ||
| EPS, 1Y Change | +100.00% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:15 | |
| Next Split | N/A | N/A |
| Last Ticker Change | MNMD | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| EPS Estimate | N/A | -$1.91 |
| EPS Est. Change | N/A | - |
| $0.00 | ||
| Revenue Estimate | N/A | - |
| Revenue Est. Change | N/A | - |
| Current Price | $17.66 | |
| Price Target | - | $26.50 |
| Price Tgt. Change | - | +50.06% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$2.01 | $0.00 | +100.00% | |
| -$1.91 | N/A | - | |
| -$1.70 | N/A | - |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | N/A | - | |
| $39.36M | N/A | - |
🔒 Log In To Unlock Full Data
Performance
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $17.66 | |
| $11.58 | ||
| SMA 200 vs Price | -34.45% | |
| $16.09 | ||
| SMA 50 vs Price | -8.87% | |
| 1.52 | ||
| $1.05 | ||
| 57.03 | ||
| 27.63% | ||
| 66.55% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| $0.00 | ||
| $0.00 | ||
| - | ||
| -$166.31M | ||
| - | ||
| -$183.79M | ||
| - | ||
| -$166.31M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.12 | ||
| 6.29 | ||
| 6.29 | ||
| - | ||
| - | ||
| 8.67 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| 5.17 | ||
| -8.09 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $332.33M | ||
| $411.59M | ||
| $440.10M | ||
| $419.32M | ||
| $107.77M | ||
| $66.70M | ||
| $40.58M | ||
| $0.00 | ||
| $5.35M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $183.79M | ||
| $166.31M | ||
| $0.00 | ||
| $48.64M | ||
| $0.00 | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$131.56M | ||
| -$151.61M | ||
| $267.27M | ||
| $0.00 | ||
| -$131.56M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Wolfe Research | ||
| Jefferies | ||
| RBC Capital | → |
Analyst sentiment
Institutional ownership
Screeners with DFTX
FAQ
What is the ticker symbol for Definium Therapeutics, Inc.?
The ticker symbol for Definium Therapeutics, Inc. is NASDAQ:DFTX
Does Definium Therapeutics, Inc. pay dividends?
No, Definium Therapeutics, Inc. does not pay dividends
What sector is Definium Therapeutics, Inc. in?
Definium Therapeutics, Inc. is in the Healthcare sector
What industry is Definium Therapeutics, Inc. in?
Definium Therapeutics, Inc. is in the Biotechnology industry
What country is Definium Therapeutics, Inc. based in?
Definium Therapeutics, Inc. is headquartered in United States
When did Definium Therapeutics, Inc. go public?
Definium Therapeutics, Inc. initial public offering (IPO) was on January 6, 2026
Is Definium Therapeutics, Inc. in the S&P 500?
No, Definium Therapeutics, Inc. is not included in the S&P 500 index
Is Definium Therapeutics, Inc. in the NASDAQ 100?
No, Definium Therapeutics, Inc. is not included in the NASDAQ 100 index
Is Definium Therapeutics, Inc. in the Dow Jones?
No, Definium Therapeutics, Inc. is not included in the Dow Jones index
When was Definium Therapeutics, Inc. last earnings report?
Definium Therapeutics, Inc.'s most recent earnings report was on February 26, 2026
When does Definium Therapeutics, Inc. report earnings?
The next expected earnings date for Definium Therapeutics, Inc. is May 7, 2026
Data Sources & References
- DFTX Official Website definiumtx.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1813814/000119312526076742/0001193125-26-076742-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1813814/000119312526076742/0001193125-26-076742-index.htm
- DFTX Profile on Yahoo Finance finance.yahoo.com/quote/DFTX
- DFTX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/dftx